Alyeska Investment Group’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q4
Sell
-9,715
Closed -$1.89M 466
2014
Q3
$1.89M Buy
9,715
+1,286
+15% +$250K 0.04% 281
2014
Q2
$2.06M Buy
8,429
+5,096
+153% +$1.25M 0.05% 279
2014
Q1
$884K Sell
3,333
-3,614
-52% -$959K 0.02% 250
2013
Q4
$2.52M Buy
+6,947
New +$2.52M 0.1% 181